HR 2542 · in committee · major
Old Drugs, New Cures Act
- healthcare
What this bill does
- Drug makers can exempt older medications from certain Medicaid and Medicare rebate requirements if researching new uses.
- This affects pharmaceutical manufacturers and patients covered by Medicaid, Medicare, and federal health programs.
- The exemption applies to drugs approved at least 10 years ago being studied for new medical purposes with significant unmet needs.
Generated by claude-haiku-4-5
Community Threads
Started by Cosponsor
- 01
How would exempting older drugs from rebate requirements affect medication prices for Medicare and Medicaid patients who rely on these medications?
- 02
What evidence supports the claim that reducing rebate requirements will actually incentivize pharmaceutical companies to research new uses for these older drugs?
- 03
Which older medications might qualify for exemption under this bill, and what new treatments could result from the research incentives it creates?
Cosponsor writes these to seed civic discussion — they aren't user posts. Sign in to reply.
Sponsor · D-NC-1
Donald G. Davis
Citizen cosponsors
0
In Congress
1/ 435
House Reps cosponsoring
Introduced 2025-04-01
Joining the bill
Legislative timeline
2025-04-01 · house · IntroReferral
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2025-04-01 · house · IntroReferral
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2025-04-01 · IntroReferral
Introduced in House
2025-04-01 · IntroReferral
Introduced in House
Citizen comments
Sign in to comment on this bill.
No comments yet — be the first.